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ABSTRACT 
Gastro-retentive drug delivery system (GRDDS) has gained immense popularity in the field of oral drug delivery recently. It is a widely employed 
approach to retain the dosage form in the stomach for an extended period of time and release the drug slowly that can address many challenges 
associated with conventional oral delivery, including poor bioavailability. The main limitations are attributed to the inter- and intra-subject 
variability of gastro-intestinal (GI) transit time and to the non-uniformity of drug absorption throughout the alimentary canal. It is known that 
differences in gastric physiology, such as gastric pH, and motility exhibit both intra-as well as inter-subject variability demonstrating significant 
impact on gastric retention time and drug delivery behavior. This triggered the attention towards formulation of stomach specific (gastro 
retentive) dosage forms. Floating or hydro dynamically controlled drug delivery systems are useful in such applications. The drugs having 
absorption window in the upper part of Gastro Intestinal Tract (GIT) have enhanced bioavailability when formulated through these techniques.  
The recent technological development for enhancing GRT including the physiological and formulation variables affecting gastric retention. The 
developed system has the dual advantages of being gastro-retentive, to increase oral bioavailability and releasing drug in a controlled manner.  
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Floating systems, first described by Davis in 1968, are low-
density systems that have sufficient buoyancy to float over 
the gastric contents and remain in the stomach for a 
prolonged period .While the system floats over the gastric 
contents, the drug is released slowly at the desired rate, 
which results in increased GRT and reduces fluctuation in 
plasma drug concentration.  
An ulcer is a round or oval shaped hole (also called parietal 
defect), 2 to 4 cm in diameter with perpendicular borders 
and a smooth base.  A Peptic Ulcer is an ulcer in the 
gastrointestinal tract that is characteristically acidic and thus 
extremely painful. It is also called ulcers pepticum or peptic 
ulcer disease (PUD). Contrary to general belief peptic ulcers 
happen more often in the duodenum first part of the small 
intestine than in the stomach.3,17   
Floating microspheres are gastro-retentive drug delivery 
systems based on non-effervescent approach. The oral route 
is predominant and most preferred route for drug delivery 
but drug absorption is unsatisfactory and highly variable in 
the individuals despite excellent in-vitro release pattern. The 
major problem is in the physiological variability such as GI 
transit in addition to gastric retention time (GRT), the later 
plays a dominating role in overall transit of the dosage 
forms. The GRT of ever oral controlled release system is less 
than 12 h. These aspects lead to developing a drug delivery 
system which will remain in the stomach for prolonged and 
predictable time.18 
These have a bulk density lower than the gastric content. They 
remain buoyant in the stomach for a prolonged period of time, 
with the potential for continuous release of drug. Eventually the 
residual system is emptied from the stomach. Gastric emptying 
is much more rapid in the fasting state and floating systems rely 
heavily on the presence of food to retard emptying and provide 
sufficient liquid for effective buoyancy. The amount, nature and 
caloric content of the food and the frequency of feeding 
profoundly affect gastric retention.19 
To develop oral drug delivery system, it is necessary to optimize 
both the residence time of the system within the gastrointestinal 
tract and the release rate of drug from the system. Various 
attempts have been made to prolong the residence time of 
dosage forms within the stomach. The prolongation of gastric 
residence time (GRT) of delivery devices could be achieved by 
adhesion to the mucous membranes by preventing there 
passage through pylorus, using high density systems, delayed 
gastric emptying devices or by maintaining them in buoyant 
fashion in gastric juice.10 
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Figure 1: Drug absorption from (a) conventional dosage forms and (b) gastroretentive drug delivery system 
 
MATERIALS AND METHODS  
Nizatidine hydrochloride was generously supplied as a gift 
samples by Dr. Reddy Laboratories Hyderabad and 
Amoxicillin was a gift sample obtained from biocon, 
Bangalore (India).  Polymethylmethacrylate, 
Dichloromethane and Dimethylformamide were purchased 
from CDH India. All other chemicals and reagents were used 
of analytical grade.  
Preparation of floating microspheres by (solvent 
evaporation method) 
Floating microspheres were prepared by Solvent 
evaporation (oil-in–water emulsion) technique. In this 
225mg polymethyl methacrylate (PMMA) were dissolved in 
a mixture of dimethyl formamide and dichloromethane (1:1) 
at room temperature. And 100mg Nizatidine hydrochloride 
and 75mg Amoxicillin Hydrochloride were added in the 
above mixture. This was poured into 250ml water containing 
0.02% tween 80, maintained at a temperature 30-40oC and 
subsequent stirred at ranging agitation speed for 20 minute 
to allow the volatile solvent to evaporate.16 The 
microspheres formed were filtered, washed with water and 






                                      













Figure 2:  Schematic representation of method of preparation of Floating microspheres 
 
Characterization of prepared floating microspheres 
The prepared floating microspheres were characterized for 
shape and surface morphology, size, percent drug loading 
and in vitro drug release in different GIT PH. 
Shape and surface morphology 
In order to examine the surface morphology, the 
formulations were viewed under scanning electron 
microscopy. The samples for SEM were prepared by lightly 
sprinkling the floating microspheres powder on a double 
225mg of polymethyl methacrylates (PMMA) 
dissolved in mixture of dimethylformamide and 
dichloromethane. (1:1) ratio. 
Mixture of Nizatidine 
Hydrochloride (100mg) and 
Amoxicillin (75mg) 




Collection of Floating Microspheres 
Add 
     Mechanical Stirring 400 rpm : 30-40
o
C  
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adhesive tape, which stuck to an aluminum stub. The stubs 
were then coated with gold to a thickness of about 300Å 
using a sputter water. The samples were then randomly 
scanned for studying surface morphology but show the 
images of coating to prove internal surface.4, 6 
Particle size determination 
The particle size of formulation was determined by optical 
microscopy using a calibrated ocular micrometer.9 
% Drug Entrapment 
100 mg of floating microspheres was dissolved in 3 ml of 
dichloromethane and shaken vigorously for 2 min. The 
solution was then filtered through 0.45µm syringe filter 
(Millipore Millex HN, USA). After suitable dilution with PBS 
(pH 7.4) solution was assayed for combined drug 
spectrophotometrically.9 The percent drug entrapped was 
calculated. 
%  DE  =  100
expected load  drug lTheoretica 
present actually  drug ofAmount 

 
In Vitro buoyancy test of optimized floating 
microspheres formulation 
The floating test of the prepared optimized floating 
microspheres formulation was carried out using dissolution 
test apparatus USP XXII method II. 500 mg of floating 
microspheres were immersed in 900 ml simulated gastric 
fluid SGF (pH 1.2) maintained at 37 ± 2°C, which was 
agitated by a paddle rotated at 100 rpm. The paddle blades 
were positioned at the surface of dissolution medium. The 
floating microspheres floating on the surface of SGF (pH 1.2) 
were recovered with a sieve No. 120 (34µm) at every 1 hr 
time interval for 8 hours. The floating microspheres so 
collected were dried and weighed. The floating percentage of 
the floating microspheres was defined as the weight ratio of 
the floating microspheres against the total weight of floating 
microspheres in the floating test.7, 4 The buoyancy of the 








Where Qf and Qs are the weights of the floating and settled 
floating microspheres respectively.
 In Vitro Buoyancy of Floating Microspheres In SGF (PH 
1.2)  
 
After (0 hr)         After (2 hrs.) 
 
After (4 hrs)         After (6 hrs.) 
 
After (8 hrs)            After (12 hrs.) 
Figure 3: Photographs of in vitro buoyancy of floating 
microspheres in SGF (pH 1.2) 
In Vitro drug release in different gastrointestinal fluids 
Optimized formulation was evaluated for the in vitro drug 
release study in different GIT fluids. The dissolution test of 
floating microspheres was carried out by the paddle type 
dissolution apparatus specified in USP XXIII under perfect 
sink condition.9 
500 mg of floating microspheres was weighed accurately and 
gently spread over the surface of 500 mL of dissolution 
medium. The media was rotated at 100 rpm and 
thermostatically controlled at 372°C. Perfect sink condition 
was prevailed during the drug dissolution. The release was 
tested in dissolution medium of pH 1.2, pH 6.8 and pH 7.4 
solutions.10 An aliquot of the release medium was withdrawn 
at every 1 hr time interval and an equivalent amount of fresh 
medium was added to the release medium. The collected 
samples were filtered through 0.45µm-syringe filter 
(Millipore millex HN) and after suitable dilution sample were 
analyzed spectrophotometrically. % cumulative drug release 
are Calculated. 
Stability Studies 
The stability of a preparation is usually defined as the 
capacity of the formulation to remain within defined limits 
over a predetermined period of time and is known as shelf 
life of the product. Stability of a formulation may also be 
defined as the capability of a particular formulation 
packaged in a specific container to remain within its physical, 
chemical, microbiological, therapeutic and toxicological 
specifications. A stable drug delivery system should maintain 
its integrity and morphology, and at the same time should 
preserve various characteristics such as nature of the 
entrapped drug, drug content and release rate etc. In most of 
the stability studies, the major emphasis has been directed 
towards the accelerated stability studies but the stability 
studies of aged products have been of greater 
pharmaceutical significance.8 
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 The stability of the drug-loaded floating microspheres 
during storage is undoubtedly another important 
prerequisite for its successful clinical application. 
Degradation is likely to occur under tropical conditions of 
higher ambient temperature and humidity. Hence the 
prepared floating microspheres were subjected to 
accelerated stability testing.  
Effect of storage on structural integrity of optimized 
floating microspheres formulation 7, 9 
The optimized formulation was stored in amber colored 
glass bottles at 41°C, 251°C and 401°C for a period of 45 
days and observed for any change in particle size (optical 
microscopy) and surface morphology by phase contrast 
microscope (Leica MPS, Germany).  
Effect of storage on residual drug content 
Stability of floating microspheres formulations on storage is 
of great concern as it is the major factor in their development 
as marketed preparation. The prepared formulation was 
tested for stability at 41°C, 251°C and 401°C 
temperatures. Formulation was stored in amber colored 
glass vials, and then it was evaluated after 15, 30 and 45 days 
for change in residual drug content.7 For the determination 
of residual drug content floating microspheres formulation 
were dissolved in 3ml dichloromethane filter through 
polycarbonate membrane (Millipore, USA) of 200 nm pore 
size than after suitable dilution with PBS (pH 7.4) the drug 
content estimated spectrophotometrically using UV-visible 
spectrophotometer (Shimdazu 1800, Japan).2 
In Vivo radiographical study 5 
In order to assess the gastro retentive efficacy of floating 
formulations, the Percent buoyancy in a biological system 
was determined by using barium sulphate X-ray contrast 
medium containing 15% barium sulphate as a contrast agent 
were prepared for radio graphical study. The study was 
carried out with one healthy male rabbits free of detectable 
gastrointestinal diseases or disorders. The study was carried 
out under the guidelines compiled by CPCSEA (Committee 
for the purpose of control) Supervision of Experiments on 
Animal, Ministry of Culture, Government of India and the 
local institutional Animal Ethics Committee approved all the 
study protocols. The rabbits were fasted overnight. The 
rabbits were administered optimized floating microspheres 
formulation with 25ml of water and X- ray photograph was 
taken after every one hour  of administration and 
intragastric behavior of the floating microspheres was 
observed by taking a series of X- ray photographs at different 
time intervals. 
In-vivo studies 
 Albino rat of either sex weighing 400 – 450 gm were chosen 
for the present studies. All in vivo studies on animals were 
approved by animal ethical committee of the Oriental 
University, Indore (MP), India constituted under the 
guidelines of CPCSEA, New Delhi, India through their vide 
letter no. animal eths. Comm./10/87/35 dated 20/22-11-17. 
Induction of Gastric Ulcer 20, 22  
The experiment was conducted on Albino rat, whose average 
body weight of 400 – 450 gm and age nearly 03 month. 
Animals were kept in standard cages for constant room 
temperature at 25 ± 1 0C. Rats were keep in Fasted condition 
for 18 hour where no food but water was provided ad-
libitum. Gastric Ulcers were induced by administered 
ethanol in the range of (95%, 01ML/200gm body weight) 
orally through a feeding tube. 
Experimental design:  
The animals were divided into three groups and each group 
consisting of five rats. Group-1:  group provided Normal 
Saline. Group-2: Nizatidine solution (10 mg /ml) was 
administered orally Group-3: Nizatidine Hydrochloride 
Loaded Microspheres (equivalent to 10 mg). After 
administration of above mentioned formulations, animals 
were sacrificed, and the abdomen was opened by midline 
incision and stomach was removed, opened along the greater 
curvature, rinsed gently with water and pinned for 
macroscopic examination, upon examination gastric lesion 
were measured and ulcer index (UI) was estimated.20  
                            UI   =           Ulcerated area (mm2)  
                                              Total stomach area (mm2) 
RESULT AND DISCUSSION 
Floating microspheres were prepared by solvent 
evaporation method. Polymethylmethacrylate (225mg) was 
dissolved in a mixture of dimethylformamide and 
dichloromethane (1:1) at room temperature and drug 
combination (175mg) was dispersed in above mixture. This 
drug-Polymer mixture was poured into 250ml water 
containing 0.02% tween 80, maintained at a temperature 
30–40oC, and subsequent stirred at ranging agitation speed 
300-400rpm to allow the volatile solvent to evaporate. The 
microsphere formed were filtered, washed and dried in 
vacuum. 
For this floating microspheres formulation were prepared 
with varying drug concentration viz. 25, 50, 75mg. It was 
observed that on increasing the concentration of drug, the 
entrapment efficiency increased. While on further increasing 
drug concentration the entrapment efficiency gradually 
decreased. 
Average particle size of floating microspheres reduces with 
increased in temperature. Narrow size distribution 
131.41.6µm   and 89.51.4% entrapment efficiency was 
found to formulation at 370C temperature. In vitro floating 
test of optimized floating microspheres formulation was 
studied in SGF (pH 1.2).  
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Figure 4: SEM photograph of Nizatidine hydrochloride floating microsphere 
The results showed that the percentage buoyancy of 
floating microspheres formulation was significantly 
decreased after 5 hr.The buoyancy (%) of optimized 
Nizatidine hydrochloride floating microspheres formulation 
in SGF (pH 1.2) are reported. 
 
 
Figure 5: Percent buoyancy of optimized nizatidine hydrochloride Floating microspheres formulations in SGF (pH 1.2) 
 
In vitro drug release from optimized floating microspheres 
were carried out in SGF (pH 1.2), SIF (pH 6.8) and PBS (pH 
7.4) by dissolution test of floating microspheres was carried 
out by the paddle method specified in the U.S.P. XXI.  No 
initial burst release was observed in any medium suggested 
that the nizatidine hydrochloride molecules are entrapped 
over the floating microspheres. The percent Cumulative 
amount of drug release was found 87.22.6% in SGF   (pH 
1.2), 90.23.5% in SIF (pH 6.8) and 93.23.5 % in PBS (pH 
7.4) upto 24 hrs. The results clearly suggest that floating 
microspheres formulation could also be utilized for 
sustained and drug delivery purpose. 
 
 
Figure 6: Percent cumulative drug release from optimized floating microspheres formulation in SFG (pH 1.2) 
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Figure 7: Percent cumulative drug release from optimized floating microspheres formulation in SFG SIF (pH 6.8) 
 
Figure 8: Percent cumulative drug release from optimized floating microspheres formulation in PBS (pH 7.4) 
 
Stability studies were carried out with optimized floating 
microspheres formulation which was stored for a period of 
45 days at 4±1°C, 25±1°C and 40±1°C. The particle size of 
formulation was determined by optical microscopy using a 
calibrated ocular micrometer. The particle size of the floating 
microspheres was found to increase at 25±1°C, which may 
be attributed to the aggregation of floating microspheres at 
higher temperature. At 401°C the floating microspheres 
aggregated and a no change in spherical shape. to ellipsoidal 
shape with irregular observed i.e. these floating 




Figure 9: Effect of storage temperature on particle size of optimized floating microspheres formulation 
The selected optimized floating microspheres formulation 
was stored at 4±1°C, 25±1°C and at 40±1°C and the residual 
drug content of the formulation was determined after 15, 30 
and 45 days. It was observed that the formulation stored at 
4±1°C and 25±1°C was quite stable as fewer drugs was 
degraded on storage for 45 days while it was quite unstable 
at 40±1°C for 45 days.
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Figure 10: Percent residual drug content in optimized floating microspheres formulation stored at different 
temperatures 
 
The in vivo study with X-ray contrast medium containing 
floating microspheres was conducted to determine the in 
vivo floating performance of optimized floating microspheres 
formulation. X-ray photograph taken after each 1hr interval 
shows intragastric behavior of the floating microspheres. It 
is clear from the X-ray photographs that floating 
microspheres remained buoyant even after 4 hrs which is a 
satisfactory time for a gastro retentive property obtained by 




Figure 11: X-ray photographs showing  floating microspheres remained buoyant 
                 
In case of Invivo Study the ethanol induced ulcer model, the 
oral administration of 95% ethanol in control group, produce 
characteristic lesions in the stomach which shows as the 
bands of broad red lesions. The In vivo evaluation showed 
the Ulcer Index (UI) were, 0.64 ± 0.08 for Group 1 (Normal 
saline –treated group), 0.49 ± 0.11 for Group 2 (Nizatidine 
solution) and 0.14 ± 0.08 for Nizatidine microspheres. 
Microspheres -treated group showed significant (p < 0.01) 
ulcer protection index as compared to free drug-treated 
group.
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(a) Control group showing              (b)Nizatidine solution–treated          (c) Nizatidine loaded                
                  normal gastric integrity                     group (100 mg/kg)                                   Microspheres –treated group 
Figure 12: Evidence for the protective effect of Nizatidine loaded  Microspheres in rats treated with ethanol 
                              
Table 1: Anti ulcer effect of Nizatidine Hydrochloride formulation on Ethanol Induced Gastric Ulcer 
Values are expressed as Mean±SEM, n = 5 in each group. **p<0.01, ***p<0.001 
 
CONCLUSION 
 The result obtained from all the experiments perform as a 
part of project work suggested that it is possible to prepare 
an intragastric floating and sustained release floating 
microspheres preparation using Polymethylmethacrylate, 
solvent evaporation method. Floating microspheres drug 
delivery system provides the possibility of enhancing the 
bioavailability and control the release of formulation 
exhibiting absorption window by prolonging the gastric 
emptying time of the dosage form ensuring availability of 
drug at the absorption site for the desired period of time. As 
the floating microspheres showed a good buoyancy and drug 
release properties so that it has a great potential for its use 
both in powder form for dry suspension and granular form 
for table ting.  
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Group Mean volume of 
Gastric secretion 
Mean PH Mean total acid Ulcer index 
Control (Normal Saline) 3.22 ±0.15 4.53 ±0.04 93.5 ±1.01 0.64 ± 0.08 
Nizatidine Hydrochloride 
Solution (Standard)  
2.54 ±0.15** 5.83 ±0.80*** 108 ±0.04*** 0.49 ± 0.11*** 
Nizatidine Hydrochloride 
Loaded Formulation  
2.66 ±0.23** 5.64 ±0.51** 112 ±0.50** 0.14 ± 0.08** 
